BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21523438)

  • 1. NMR assignments of ubiquitin fold domain (UFD) in SUMO-activating enzyme subunit 2 from rice.
    Suzuki R; Tsuchiya W; Shindo H; Yamazaki T
    Biomol NMR Assign; 2011 Oct; 5(2):245-8. PubMed ID: 21523438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions.
    Liu B; Lois LM; Reverter D
    Sci Rep; 2017 Feb; 7():41998. PubMed ID: 28165030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.
    Lois LM; Lima CD
    EMBO J; 2005 Feb; 24(3):439-51. PubMed ID: 15660128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
    Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
    Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K; Lee TD; Chen Y
    J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into SUMO E1-E2 interactions in Arabidopsis uncovers a distinctive platform for securing SUMO conjugation specificity across evolution.
    Liu B; Lois LM; Reverter D
    Biochem J; 2019 Jul; 476(14):2127-2139. PubMed ID: 31292170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importin α/β mediates nuclear import of individual SUMO E1 subunits and of the holo-enzyme.
    Moutty MC; Sakin V; Melchior F
    Mol Biol Cell; 2011 Mar; 22(5):652-60. PubMed ID: 21209321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2-binding surface on Uba3 β-grasp domain undergoes a conformational transition.
    Elgin ES; Sökmen N; Peterson FC; Volkman BF; Dağ C; Haas AL
    Proteins; 2012 Oct; 80(10):2482-7. PubMed ID: 22821745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM; Rodriguez MS; Kemp GD; Hay RT
    J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes.
    Lee I; Schindelin H
    Cell; 2008 Jul; 134(2):268-78. PubMed ID: 18662542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
    Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structures and DNA binding properties of the N-terminal SAP domains of SUMO E3 ligases from Saccharomyces cerevisiae and Oryza sativa.
    Suzuki R; Shindo H; Tase A; Kikuchi Y; Shimizu M; Yamazaki T
    Proteins; 2009 May; 75(2):336-47. PubMed ID: 18831036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR structural studies of the first catalytic half-domain of ubiquitin activating enzyme.
    Jaremko M; Jaremko Ł; Nowakowski M; Wojciechowski M; Szczepanowski RH; Panecka R; Zhukov I; Bochtler M; Ejchart A
    J Struct Biol; 2014 Jan; 185(1):69-78. PubMed ID: 24211821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications.
    Wang J; Hu W; Cai S; Lee B; Song J; Chen Y
    Mol Cell; 2007 Jul; 27(2):228-237. PubMed ID: 17643372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation.
    Boggio R; Passafaro A; Chiocca S
    J Biol Chem; 2007 May; 282(21):15376-82. PubMed ID: 17392274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.